Hummingbird Bioscience bags $35.3m in series B funding round

SK Holdings led the series B extension as a new investor.

Biotherapeutics company, Hummingbird Bioscience, has closed an extended series B funding round of $35.3m (US$25m), according to an announcement, bringing the company's total capital raised through financing activities and strategic partnerships to more than $91.78m (US$65m).

SK Holdings led the series B extension as a new investor, with participation from existing shareholders, including Heritas Capital and SEEDS Capital, the investment arm of Enterprise Singapore.

The extension of the series B round to $35.3m (US$25m) is said to be due to over-subscription, with the addition of select quality and value-add investors.

Hummingbird will use the new funds to accelerate development of new candidates into clinical trials and strengthen its scientific and research and development capabilities.

Earlier this year, Hummingbird announced publication of positive data on its lead candidate, HMBD-001, a unique HER3 antibody, and manufacturing of HMBD-002, a first-in-class VISTA antibody. Regulatory submissions to initiate Phase I studies for these are expected in H2 2020.

The people you want to reach are already in this room.

Every quarter, SBR lands on the desks of the founders, CFOs, and directors running Asia's most consequential companies. Every day, they open our newsletter and read our website. It's a room that took twenty years to build — and it's the one most of our partners are trying to get into.

The good news is that the door is open. We work with companies on thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. The shape of the right partnership depends on what you're trying to do, which is why we'd rather start with a conversation than send a rate card.

If you have something this room should know about, tell us. We'll tell you honestly whether we can help, and how.

No rate cards until we understand the brief. It's a better use of everyone's time.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia